UBX logo

Unity Biotechnology (UBX) Company Overview

Profile

Full Name:

Unity Biotechnology, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

May 3, 2018

Indexes:

Not included

Description:

Unity Biotechnology focuses on developing therapies to slow or reverse age-related diseases. The company aims to improve healthspan by targeting cellular senescence, which contributes to aging and age-related conditions. Their innovative approach seeks to enhance the quality of life for older adults through advanced biotechnology solutions.

Events Calendar

Earnings

Next earnings date:

Apr 15, 2025

Recent quarterly earnings:

Nov 4, 2024

Recent annual earnings:

Apr 15, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 20, 2022

Analyst ratings

Recent major analysts updates

Jan 10, 25 Chardan Capital
Buy
Aug 8, 24 HC Wainwright & Co.
Buy
May 15, 24 HC Wainwright & Co.
Buy
Apr 16, 24 HC Wainwright & Co.
Buy
Nov 16, 23 Wedbush
Outperform
Nov 14, 23 HC Wainwright & Co.
Buy
Aug 9, 23 HC Wainwright & Co.
Buy
Jun 26, 23 Wedbush
Neutral
May 31, 23 Roth MKM
Buy
May 26, 23 Citigroup
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Unity Biotechnology?
  • Does Unity Biotechnology pay dividends?
  • What sector is Unity Biotechnology in?
  • What industry is Unity Biotechnology in?
  • What country is Unity Biotechnology based in?
  • When did Unity Biotechnology go public?
  • Is Unity Biotechnology in the S&P 500?
  • Is Unity Biotechnology in the NASDAQ 100?
  • Is Unity Biotechnology in the Dow Jones?
  • When was Unity Biotechnology's last earnings report?
  • When does Unity Biotechnology report earnings?
  • Should I buy Unity Biotechnology stock now?

What is the ticker symbol for Unity Biotechnology?

The ticker symbol for Unity Biotechnology is NASDAQ:UBX

Does Unity Biotechnology pay dividends?

No, Unity Biotechnology does not pay dividends

What sector is Unity Biotechnology in?

Unity Biotechnology is in the Healthcare sector

What industry is Unity Biotechnology in?

Unity Biotechnology is in the Biotechnology industry

What country is Unity Biotechnology based in?

Unity Biotechnology is headquartered in United States

When did Unity Biotechnology go public?

Unity Biotechnology's initial public offering (IPO) was on May 3, 2018

Is Unity Biotechnology in the S&P 500?

No, Unity Biotechnology is not included in the S&P 500 index

Is Unity Biotechnology in the NASDAQ 100?

No, Unity Biotechnology is not included in the NASDAQ 100 index

Is Unity Biotechnology in the Dow Jones?

No, Unity Biotechnology is not included in the Dow Jones index

When was Unity Biotechnology's last earnings report?

Unity Biotechnology's most recent earnings report was on Nov 4, 2024

When does Unity Biotechnology report earnings?

The next expected earnings date for Unity Biotechnology is Apr 15, 2025

Should I buy Unity Biotechnology stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions